Biotech Acquisition Company (BIOT)
| Market Cap | 250.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 25.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
News
Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering.
Biotech Acquisition Company has filed to go public with an IPO on the NASDAQ.
About BIOT
Biotech Acquisition is a recently organized blank check company incorporated as a Cayman Islands exempted company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one business. We intend to focus on industries that complement our sponsor and management team’s background as affiliates of SPRIM Global Investments, a leading life science investment firm in the healthcare industry. As such, our target sector is expected to be the healthcare... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Pending |
| CEO Michael Shleifer | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol BIOT |